Ben Hindson
yarraben.bsky.social
Ben Hindson
@yarraben.bsky.social
Radiation oncologist In Christchurch NZ. #ThisIsBrachytherapy #Prostatecancer
Paediatric and adult oncologist
Reposted by Ben Hindson
#medsky #pedsky #oncosky #pedsurgsky
@chirpedbicetre.medsky.social has just published a paper on combining surgery and brachytherapy for bladder-prostate rhabdomyosarcoma.
This technique used for 30 years till now, benefits to many children all over the world.
www.sciencedirect.com/science/arti...
Conservative surgery and brachytherapy in pediatric bladder-prostate rhabdomyosarcoma: technical tips and tricks
Bladder-prostate rhabdomyosarcoma (BP-RMS) is a rare pediatric malignancy. Historically, treatment involved radical surgery and or radiotherapy with i…
www.sciencedirect.com
August 8, 2025 at 11:31 AM
Reposted by Ben Hindson
a lot of people think you need a lot of money to buy clothes. now you're right. ok. my bad.
April 7, 2025 at 11:41 PM
Reposted by Ben Hindson
Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance

academic.oup.com/jncics/advan...

Suggest active surveillance doesntt have significant detrimental effect on functional outcomes, supportin for men w/low & favorable intermediate-risk PCa
Functional outcomes after primary vs delayed robot-assisted radical prostatectomy following active surveillance
AbstractBackground. It is unknown if a period of active surveillance before prostatectomy for prostate cancer (PCa) worsens functional outcomes. The aim of
academic.oup.com
February 24, 2025 at 9:05 AM
Reposted by Ben Hindson
This article evaluates the overall survival (OS) and local recurrence (LR) in patients with grade 2 #meningiomas treated with adjuvant #radiotherapy compared to surgery alone at time of diagnosis.

Read more about their research: https://buff.ly/3ZUe43k

@syip.bsky.social
January 31, 2025 at 12:07 PM
Reposted by Ben Hindson
Check out this comprehensive and timely review in @lancet.bsky.social by our RadOnc group @PennMedicine.bsky.social on #radiotherapy related toxicities and the latest approaches to mitigate them. Congrats to @YiannisVerginadis.bsky.social who led this effort. www.thelancet.com/journals/lan...
Radiotherapy toxicities: mechanisms, management, and future directions
For over a century, radiotherapy has revolutionised cancer treatment. Technological advancements aim to deliver high doses to tumours with increased precision while minimising off-target effects to or...
www.thelancet.com
February 4, 2025 at 1:15 AM
Reposted by Ben Hindson
Exciting news! Our Red Journal invited editorial on sim-free RT is now available! @ijrobp.bsky.social @drdavidpalma.bsky.social
Grateful for the opportunity to contribute to this discussion! Check it out here: authors.elsevier.com/c/1kYHc1Hx52... #simfreeRT #radiotherapy #palliativeRT #OpenAccess
February 3, 2025 at 2:56 PM
Reposted by Ben Hindson
Word of day is ‘unasinous’ (17th century): united in stupidity.

A riff on ‘unanimous’: which comes from the Latin for ‘one mind’. ‘Unasinous’ means ‘one ass’.
January 22, 2025 at 9:05 AM
Reposted by Ben Hindson
How does #prostatecancer recur after radiotherapy?

Alisha Pati-Alam, Susan Heavey and the team at UCL highlight this key question in their commentary of an important new meta-analysis on salvage therapies.

Grab a ☕and read more: doi.org/10.1038/s413...
January 22, 2025 at 9:08 AM
Reposted by Ben Hindson
#PEACE3 confirmed efficacy of combo of #Enzalutamide & #Ra223. For any treatment, safety & toxicity equally important. Read our recommendations on use of bone protection @eortc.bsky.social @mcrcnews.bsky.social @ccparker.bsky.social
👇🏽👇🏽👇🏽👇🏽👇🏽👇🏽👇🏽
www.sciencedirect.com/science/arti...
Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis
Bone health is central to the management of patients with metastatic castration-resistant prostate cancer (mCRPC). International guidelines recommend …
www.sciencedirect.com
January 20, 2025 at 8:07 AM
Reposted by Ben Hindson
Stereotactic Radiation Therapy for Localized Prostate Cancer: 10-Year Outcomes From Three Prospective Trials out on the RedJournal

www.redjournal.org/article/S036...

Overall, SABR provides durable disease control for localized prostate cancer with manageable risks.
Stereotactic Radiation Therapy for Localized Prostate Cancer: 10-Year Outcomes From Three Prospective Trials
SABR is growingly accepted for the treatment of localized prostate cancer with recent randomized trials showing noninferiority compared with conventional or moderately hypofractionated radiation thera...
www.redjournal.org
January 16, 2025 at 4:32 PM
Reposted by Ben Hindson
Spectacular results! Consolidation #radiotherapy for gallbladder cancer improves survival and maintains quality of life.
Congratulations to the study team.
The RACE-GB trial results are here! FIRST randomized controlled trial investigating radiotherapy (RT) in gallbladder cancer.

In a cohort of 135 patients the addition of RT after 4 cycles of chemotherapy (compared to observation) extended overall survival (OS) from 4 months to 10 months.@RadOnc
December 22, 2024 at 11:18 AM
Reposted by Ben Hindson
Pts were excluded “if after radical prostatectomy they were considered by the investigator to be a candidate for salvage radiation therapy”. Hard to extrapolate omission from this dif pop… Want +MFS/OS w/PORT: S8794. What’s the cost of enza and would men rather yrs ADT or 5wk RT (w/o ADT for many).
November 29, 2024 at 2:40 PM
Reposted by Ben Hindson
PEACE-1 published
Radiotherapy of the prostate in metastatic pts prevents serious GU complications, in pts with low and high tumor burden

How to select patients?
- all ?
- based on live expectancy ?
- response to systemic Tx ?
- prostate volume ?

www.thelancet.com/journals/lan...
Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design
Combining radiotherapy with standard of care plus abiraterone improves radiographic progression-free survival and castration resistance-free survival, but not overall survival in patients with low-vol...
www.thelancet.com
November 26, 2024 at 4:59 PM
Reposted by Ben Hindson
Anyone who is anti-vax is pro-death. Period. The science and data do not lie. And they don’t care about your podcast.
November 24, 2024 at 10:52 PM
Hey #brachy #prostatecancer and #radonc. I’m interested to hear about what people are doing for prostate salvage #brachy? Focal or whole gland and what doses. We have done a few and I am writing a department protocol so any wise words ?
November 22, 2024 at 12:15 AM
Reposted by Ben Hindson
Overall fairly low risk group of participants, but helpful information to consider when counseling patients. Will be interesting to see what stratification will occur in the PSMA PET era.

Direct link to paper: www.sciencedirect.com/science/arti...
Randomised Trial of No, Short-term, or Long-term Androgen Deprivation Therapy with Postoperative Radiotherapy After Radical Prostatectomy: Results from the Three-way Comparison of RADICALS-HD (NCT0054...
The use and duration of androgen deprivation therapy (ADT) with postoperative radiotherapy (RT) have been uncertain. RADICALS-HD compared adding no (“…
www.sciencedirect.com
November 20, 2024 at 11:52 PM